Literature DB >> 19345815

Fourth-generation fluoroquinolones in tuberculosis.

Hans L Rieder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19345815     DOI： 10.1016/S0140-6736(09)60559-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Current development and future prospects in chemotherapy of tuberculosis.

Authors:  Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

2.  Machine-learning techniques applied to antibacterial drug discovery.

Authors:  Jacob D Durrant; Rommie E Amaro
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

3.  Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.

Authors:  Zahoor Ahmad; Sandeep Tyagi; Austin Minkowski; Charles A Peloquin; Jacques H Grosset; Eric L Nuermberger
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.